DOTAREM 279,32MG/ML Injekční roztok v předplněné injekční stříkačce Czech Republic - Czech - SUKL (Státní ústav pro kontrolu léčiv)

dotarem 279,32mg/ml injekční roztok v předplněné injekční stříkačce

guerbet, roissy cdg cedex array - 10803 kyselina gadoterovÁ - injekční roztok v předplněné injekční stříkačce - 279,32mg/ml - kyselina gadoterovÁ

DOTAREM 279,32MG/ML Injekční roztok Czech Republic - Czech - SUKL (Státní ústav pro kontrolu léčiv)

dotarem 279,32mg/ml injekční roztok

guerbet, roissy cdg cedex array - 10803 kyselina gadoterovÁ - injekční roztok - 279,32mg/ml - kyselina gadoterovÁ

DOTAREM 0,5 mmol/mL, solution injectable France - French - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

dotarem 0,5 mmol/ml, solution injectable

guerbet - acide gadotérique 27 - solution - 27,932 g - pour 100 ml de solution > acide gadotérique 27,932 g sous forme de : dota 20,246 g et sous forme de : oxyde de gadolinium 9,062 g - produit de contraste paramagnétique pour irm - dotarem est un produit à usage diagnostique. il appartient au groupe des produits de contraste utilisés en imagerie par résonance magnétique (irm).ce médicament est à usage diagnostique uniquement.dotarem est administré afin d’améliorer le contraste des images obtenues lors d’un examen par irm. ceci facilite la visualisation et la délimitation de certaines parties du corps.

DOTAREM 0,5 mmol/mL, solution injectable en seringue pré-remplie France - French - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

dotarem 0,5 mmol/ml, solution injectable en seringue pré-remplie

guerbet - acide gadotérique 27 - solution - 27,932 g - pour 100 ml de solution > acide gadotérique 27,932 g sous forme de : oxyde de gadolinium 9,062 g et sous forme de : dota 20,246 g - produit de contraste paramagnétique pour irm - dotarem est un produit à usage diagnostique. il appartient au groupe des produits de contraste utilisés en imagerie par résonance magnétique (irm).ce médicament est à usage diagnostique uniquement.dotarem est administré afin d’améliorer le contraste des images obtenues lors d’un examen par irm. ceci facilite la visualisation et la délimitation de certaines parties du corps.

DOTAREM gadoteric acid 279.32mg/mL injection 20 mL pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 20 ml pre-filled syringe

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

DOTAREM gadoteric acid 279.32mg/mL injection 15 mL pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 15 ml pre-filled syringe

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

DOTAREM gadoteric acid 279.32mg/mL injection 10 mL pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 10 ml pre-filled syringe

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

DOTAREM gadoteric acid 279.32mg/mL injection 5mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 5ml vial

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

DOTAREM gadoteric acid 279.32mg/mL injection 10mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 10ml vial

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: water for injections; meglumine - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

DOTAREM gadoteric acid 279.32mg/mL injection 15mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 15ml vial

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).